ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Cortexyme Inc

Cortexyme Inc (CRTX)

1.95
0.00
(0.00%)
At close: September 20 4:00PM
1.95
0.00
( 0.00% )

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.95
Bid
1.91
Ask
1.99
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
1.95
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
42,869,000
Dividend Yield
-
PE Ratio
-1.16
Earnings Per Share (EPS)
-0.73
Revenue
-
Net Profit
-31.39M

About Cortexyme Inc

Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis or P. gingivalis, and its secreted toxic vi... Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis or P. gingivalis, and its secreted toxic virulence factor proteases called gingipains. The company operates in only one reportable segment that is developing and commercializing therapeutics. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
-

CRTX Latest News

Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010

CARY, N.C., Dec. 18 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal

CARY, N.C., Nov. 20 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (NASDAQ:CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference

CARY, N.C., Nov. 16 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

Cornerstone Therapeutics Appoints General Counsel

CARY, N.C., Nov. 13 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

Cornerstone Therapeutics Reports Third Quarter 2009 Financial Results

CARY, N.C., Nov. 4 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (NASDAQ:CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

Cornerstone Therapeutics to Host Third Quarter 2009 Conference Call

CARY, N.C., Oct. 21 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)

CARY, N.C., Sept. 3 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (NASDAQ:CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences

CARY, N.C., Sept. 3 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (NASDAQ:CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business Journal

CARY, N.C., July 20 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing products...

Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product

CARY, N.C., July 15 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (NASDAQ:CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JSPRWJasper Therapeutics Inc
$ 0.3333
(66.65%)
202
TGLTreasure Global Inc
$ 1.10
(61.69%)
2.75M
NUKKNukkleus Inc
$ 0.29
(36.47%)
10.84M
ULYUrgent ly Inc
$ 1.15
(30.37%)
7.73M
GGRGogoro Inc
$ 0.6077
(17.79%)
3.63k
PRFXPainReform Ltd
$ 0.5725
(-25.76%)
316.67k
ZJYLJin Medical International Ltd
$ 3.17
(-22.30%)
226.8k
FRESFresh2 Group Ltd
$ 1.43
(-17.34%)
14.2k
ADTXAditxt Inc
$ 0.3258
(-14.85%)
6.1M
INMInMed Pharmaceuticals Inc
$ 0.2268
(-14.38%)
45.17k
NVDANVIDIA Corporation
$ 116.06
(0.05%)
13.98M
MAXNMaxeon Solar Technologies Ltd
$ 0.088
(-3.83%)
11.1M
NUKKNukkleus Inc
$ 0.29
(36.47%)
10.84M
XPONExpion360 Inc
$ 0.0765
(-9.79%)
10.62M
INTCIntel Corporation
$ 21.9501
(0.50%)
8.22M

Discussion

View Full Feed
ccie1024 ccie1024 2 minutes ago
Bring it!
NWBO
SCAMBUSTERKING SCAMBUSTERKING 2 minutes ago
Keep loading 😂☠️😂☠️😂☠️
BCAP
BADALI BADALI 3 minutes ago
Show me if you post any your original DD on IGPK ?
Show me who others I posted all time Twitter DD ?
IGPK
PEACHMAN PEACHMAN 4 minutes ago
The total volume was less than 30,000 shares Kitty...Longs are not dumping millions of shares like you guaranteed..kitty.

IFUS longs are holding their investment in IFUS for the long term


IFUS STRONG
IFUS
dreamaker56 dreamaker56 5 minutes ago
"If you get any clue" what kind of English is that? 🤣

Go $IGPK
IGPK
Whale Gunna Whale Gunna 5 minutes ago
Bidding .0006
ADHC
I ll be back I ll be back 5 minutes ago
Steal, I thought you were smarter than this.

Yeah I saw that as well that this company has a lawsuit against them. Hopefully volume can come in enough to get out before this thing crashes to nothing. You are right. ITYS this is a SCAM!

Really, the suit you are referring
MGON
Lime Time Lime Time 5 minutes ago
CEO is young. It's a lifetime investment. It will run up huge from this price, that's guaranteed. I wish there were more OTC CEOs that would do this 🚀

The more, the merrier
BCAP
TheRealMrPirate TheRealMrPirate 6 minutes ago
Tell everyone you have no clue without yelling it out. The company hasn't been a legal entity in over 6 years. I know that doesn't register with you, oh well, so be it.
Good for Continental, they had nothing to do with former BioAmber and you haven't acknowledged the basics yet.
Good l
dreamaker56 dreamaker56 6 minutes ago
Speaking of him, surprised we haven't seen him show up.
IGPK
klonerpride klonerpride 6 minutes ago
Nice Try Jane! As Marky Marc would say Enthusiastically yours @ Dukes of Malibu!
KNOS
JusDePomme JusDePomme 7 minutes ago
Nothing to worry if u can buy .0003 here on....risk losing very low at this point!
AAPJ
dreamaker56 dreamaker56 7 minutes ago
Ok buddy, if you say so. Keep reposting other peoples posts because that's all you have. I'm pro IGPK, always have been but very critical. You seem to miss that with all your insults to me.
IGPK
theorysuit theorysuit 7 minutes ago
Please just stop, you are embarrassing. I know you are getting paid, but still bro.
NWBO
dreamaker56 dreamaker56 9 minutes ago
Exactly, but needless to say it's been a great week here at IGPK
IGPK
ChannelTrader ChannelTrader 9 minutes ago
You know she's for Trump ?
This is a Pro TRUMP Board
OMOLIVES OMOLIVES 10 minutes ago
Exactly. Embezzlement would be a blessing if that were the case. It's unfortunately worse.
mr_sano mr_sano 10 minutes ago
Does it matter? They will not come close. Remember these idiots are dangling nonbinding LOI and MOU garbage like they have done a dozen times before.

Remember successful companies preform then they release the news. When you are sucky little troll company looking to keep fleecing inv
QSEP
saturn_five saturn_five 11 minutes ago
RSLS ; Reverse split ( share consolidation ) at 1:58 ratio.
Looks like Monday 9/23/24 is effective date for R/S AND merger ...
New ticker = HIND (NASDAQ)
HIND = VYOME THERAPEUTICS , HQ in Cambridge, MA, ( Boston )
( Cambridge is home to both Harvard and M.I.T. )
Fr
RSLS
BIOCHEMUP BIOCHEMUP 11 minutes ago
Another rocket successfully deployed 🚀
RKLB
otterman otterman 11 minutes ago
Linda always has to be right, especially when the lies supporting the company come tumbling down.

Now I kinda remember when they were trying to launch into the music industry that there were some others put in charge of some things so maybe thats what shes trying to spout off on witho
DBMM
Its_TradingG Its_TradingG 11 minutes ago
Docsetc loves Chandra, hint hint! Chandra please put out an Adnexus PR!

https://x.com/supertabra55141/status/1837237384574111836?s=46

$2000 in favor of Chandra ignoring him like always lol. Do not be fooled

Docs - You're being documented, be very careful
ENZC
Investor082 Investor082 12 minutes ago
The more these pumpers post non sense, the more it becomes clear that you don't want to be a bagholder after UK approval spike!
NWBO
joe botts joe botts 13 minutes ago
I called , they had me on hold for quite awhile. I gave up after 20 minutes. Will try again , Monday.
TONR

Your Recent History

Delayed Upgrade Clock